Hillman Capital Management, Inc. is an institutional investment manager that files quarterly 13F reports with the SEC. As of Q1 2026, the fund manages $144M in reported equity holdings across 56 positions. The largest holdings are BIIB (3.8%), DD (3.7%), WBD (3.7%), GSK (3.7%), IFF (3.7%). The portfolio is concentrated in Other (88.4%), Communication Services (3.7%), Healthcare (3.4%). Data sourced from SEC EDGAR 13F filings (CIK 1314620).